...
首页> 外文期刊>Human Pathology: Case Reports >Persistent indolent pancolonic marginal zone lymphoma of MALT-type with plasmacytic differentiation – A rare post-transplant lymphoma?
【24h】

Persistent indolent pancolonic marginal zone lymphoma of MALT-type with plasmacytic differentiation – A rare post-transplant lymphoma?

机译:伴浆细胞分化的MALT型持续性顽固性泛结肠边缘区淋巴瘤–罕见的移植后淋巴瘤?

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) is associated with chronic inflammatory disorders. We present an indolent pancolonic MALT lymphoma occurring in a 39-year-old female with history of autoimmune hepatitis requiring liver transplant in 1997 and ulcerative colitis diagnosed in 2004. Random biopsies from a grossly unremarkable surveillance colonoscopy in 2015 revealed a dense monomorphic plasmacytoid infiltrate causing expansion of lamina propria without significant crypt infiltration or destruction. These cells were positive for CD79a and CD138 and showed lambda restriction; however, CD20, CD43, CD56, HHV8, and EBER were negative. A similar pancolonic infiltrate was identified in all prior colorectal biopsies from 2010 and 2012 upon retrospective review. Subsequent computed tomography of the abdomen revealed no bowel wall thickening nor enlarged lymph nodes. Bone marrow revealed involvement consistent with stage IV disease. Biopsies from 2010 and 2015 demonstrated clonal immunoglobulin gene rearrangement. MYD88 mutation was not detected. The overall features were indicative of MALT lymphoma. Although low-grade B-cell lymphomas are not considered part of the post-transplant lymphoproliferative disorder spectrum, such cases have been reported, and are typically EBV-negative. Patient underwent treatment with pentostatin for her MALT lymphoma reaching a sustained remission despite additional immunosuppression for resurgent hepatic dysfunction. To our knowledge, this is the first reported case of EBV-negative pancolonic MALT lymphoma with plasmacytic differentiation post liver transplant presenting in an indolent, asymptomatic fashion with persistence for greater than five years successfully managed without compromising the patient's liver transplant.
机译:粘膜相关淋巴组织的边缘区淋巴瘤(MALT淋巴瘤)与慢性炎症性疾病相关。我们介绍了一名39岁的女性,患有慢性胰腺炎MALT淋巴瘤,该女性在1997年发生了自身免疫性肝炎,需要进行肝脏移植,2004年诊断出溃疡性结肠炎。2015年,从不显着的监测结肠镜检查中进行的活组织检查显示,致密的单形浆细胞样浸润引起固有层的扩张而没有明显的隐窝浸润或破坏。这些细胞对CD79a和CD138呈阳性,并显示λ限制。但是,CD20,CD43,CD56,HHV8和EBER为阴性。回顾性分析,从2010年至2012年,所有先前的结肠直肠活检中均发现了类似的pancolonic浸润。随后的腹部计算机断层扫描未显示肠壁增厚或淋巴结肿大。骨髓显示受累与IV期疾病一致。 2010年和2015年的活检显示克隆免疫球蛋白基因重排。未检测到MYD88突变。总体特征提示MALT淋巴瘤。尽管低级B细胞淋巴瘤不被认为是移植后淋巴增生性疾病谱的一部分,但已报道了此类病例,通常为EBV阴性。尽管MALT淋巴瘤因复发性肝功能不全而受到额外的免疫抑制,但仍接受喷喷他汀治疗以使MALT淋巴瘤持续缓解。据我们所知,这是第一例报告的EBV阴性的全结肠MALT淋巴瘤在肝移植后呈浆细胞分化,呈无症状,无症状且持续时间超过五年,成功治疗了而又不损害患者的肝移植。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号